- Conditions
- Surgery
- Interventions
- Dexamethasone, Ropivacaine
- Drug
- Lead sponsor
- Indiana University
- Other
- Eligibility
- 2 Years to 10 Years
- Enrollment
- 8 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 1
- States / cities
- Indianapolis, Indiana
Source: ClinicalTrials.gov public record
Updated May 6, 2021 · Synced May 22, 2026, 1:30 AM EDT